Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

9 diabetes breakthroughs you need to know

May 26, 2017 By Danielle Kirsh

eyedrops

[Image from Michael McCullough on Flickr]

1. These eyedrops could prevent blindness that comes from diabetes

Eyedrops that replace eye injections could be an alternative treatment for diabetic retinopathy, according to a new study from the University of Nottingham.

Current injections are designed to target the protein called vascular endothelial growth factor (VEGF), which is what helps blood vessels form and grow naturally. Targeting VEGF stops the faulty blood cells from growing, but also stops normal blood cells from growing so that the eyes can recover from high blood sugar levels, according to a press release.

The drug that is currently injected turns off VEGF completely. It is large and therefore can only be administered through injections. Drugs that target the protein SRPK1, which promotes the growth of good VEGF blood vessels, are small enough that they can be administered through eyedrops.

Professor David Bates at Nottingham’s School of Medicine has been testing the efficacy of the eyedrops for age-related macular degeneration (AMD) and thinks it could work to prevent vision loss in diabetic patients.

“The current treatment for diabetic retinopathy is very unpleasant for the patient but also costly and time-consuming because the injection can only be performed at eye clinics by specialist doctors and nurses,” said Bates. “Eyedrops that patients could administer themselves would reduce both their discomfort and the financial burden which the current treatment places on the [the U.K.’s National Health Service].”

The AMD eyedrops are expected to be in clinical trials within the next 2 or 3 years and could have a year-long phase 3 clinical trial for diabetic patients upon completion of the first clinical trials.

Next >>

You may also like:


  • 7 companies in the race to make an artificial pancreas
  • artificial pancreas
    UVA developing smartphone-controlled artificial pancreas

  • Researchers’ bionic pancreas outperforms standard insulin pump therapy
Pages: 1 2 3 4 5 6 7 8 9 10

Related Articles Read More >

variable-stiffness-catheter
This variable stiffness catheter could simplify cardiac procedures
magnetic-tentacle-robot
This tentacle-like magnetic robot could navigate the lungs
Ukraine medtech pharma
How medtech and pharma are responding to Russia’s invasion of Ukraine
Ukraine flag
Medtech companies extend support to Ukraine humanitarian efforts

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech